NEW YORK (GenomeWeb News) – Becton Dickinson today reported $1.97 billion in revenues for its fiscal fourth quarter, down 1 percent from a year ago but in line with the consensus Wall Street estimate.

The company reported revenues of $1.99 billion in the year ago period. On a currency neutral basis revenues were up about 5 percent year over year, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.